BlogWeight-loss treatment
Weight-loss treatment
Articles on clinician-led weight management for men: who may be eligible, how a clinician assesses and reviews you, what to expect week by week, and how to choose or switch provider. The service itself is described on the medical weight loss page. Whether treatment is right for you is a clinical decision.
-
The Wegovy pill for men: what to expect week by week, from the starting dose to maintenance
The Wegovy pill (oral semaglutide) week by week: the four dose steps, the empty-stomach rule, when side effects ease and when to call your clinician.
-
Wegovy injection for men: what to expect week by week, from the starting dose to maintenance
The Wegovy injection week by week: the four dose steps to 2.4 mg, the optional 7.2 mg dose, when side effects ease and when to call your clinician.
-
Mounjaro for men: what to expect week by week, from the starting dose to maintenance
What to expect on Mounjaro (tirzepatide) week by week: the dose steps, when appetite changes, when side effects ease, and when to contact your clinician.
-
Am I eligible for medical weight loss treatment? How a UK clinician decides
Who is eligible for medical weight loss treatment in the UK, who decides, what a clinician checks before prescribing and what happens if the answer is no.
-
Weight loss programmes for men: what to look for in 2026
A checklist for judging any clinician-led weight management programme: blood testing, who reviews results, retesting, the fee and the NHS route.
-
GP or online clinician-led weight management: which is right for you?
How the NHS weight management pathway works, what a private online clinician-led programme offers, the honest limits of each, and how to decide.
-
Mounjaro hair loss in men: causes, timeline, and what you can do
Hair loss on Mounjaro is far less common in men than women. Here's what the trial data shows, the typical timeline, and how to support regrowth.
-
Mounjaro face in men: what facial changes to expect during weight loss
"Mounjaro face" is facial change from fat loss, not the drug. What men should expect, why it happens, and how protein and pacing help.
-
How to switch to HeMed from another weight loss programme
Thinking of switching weight loss programmes? How the HeMed switch works for men - eligibility, at-home blood test, and ongoing clinical monitoring.
-
Does Mounjaro affect male fertility? What the current evidence shows
Does Mounjaro affect male fertility? What the current animal and human evidence shows - and what to discuss with a clinician before starting treatment.
-
Orforglipron (Foundayo): what the MHRA licence means and what the trials showed
Orforglipron (Foundayo) is a once-daily GLP-1 weight loss pill, MHRA-approved August 2026. How it works for men and how it compares to Wegovy and Mounjaro.
-
Mounjaro results for men: what the clinical trials show month by month
What Mounjaro results look like for men month by month, based on clinical trial data, with realistic timelines and what changes beyond the scales.
-
Wegovy results for men at each dose stage: what the trials show
How men's weight loss on Wegovy builds from the starting dose to maintenance: what the clinical evidence shows at each stage and why results vary.
-
Wegovy vs Mounjaro for men: how the two compare
Wegovy vs Mounjaro for men: how the two injections differ, what the SURMOUNT-5 head-to-head trial found, and the side effects to expect.
-
Mounjaro and alcohol: what you actually need to know
Can you drink alcohol on Mounjaro? We cover the real risks, how it affects your progress, timing guidance and research on cravings.
-
How the Wegovy pill works for men: oral semaglutide explained
How the Wegovy pill (oral semaglutide) works, what the OASIS 4 trial data shows, and how the pill compares with the injection for men.
-
Retatrutide: what the Phase 3 trials show and why it is not available in the UK
Retatrutide is an investigational triple agonist in Phase 3 trials. What the data shows, its side effects, and why it is not licensed in the UK.
-
MHRA licenses oral semaglutide for weight management: what was approved
The MHRA has licensed oral semaglutide (the Wegovy pill) for weight management. What was approved, the OASIS 4 trial data, dosing and side effects.
-
GLP-1 dosing for men: a guide to optimal results
A clear guide to GLP-1 dosing for men: how Mounjaro titration works, why doses build gradually, and how to find the right dose for lasting weight loss
-
Wegovy® 7.2mg: what this new higher dose means for you
Wegovy 7.2mg is a higher maintenance dose for people already established on 2.4mg. Who it may suit, how the step-up works and the safety points to know.
-
Can men use Wegovy? A guide to eligibility
Yes - men can take Wegovy if they meet the clinical criteria. Learn the BMI thresholds, eligibility rules, and how men can start Wegovy safely in the UK.
-
Mounjaro (tirzepatide) for men: how it works, evidence and safety
How Mounjaro (tirzepatide) works, what the SURMOUNT-1 trial reported, common side effects and the safety information men should know.
-
Wegovy (semaglutide): how it works, evidence and safety
What Wegovy (semaglutide) is, how it works in the body, what the clinical trials reported, and the side effects, risks and contraindications to know.
-
What is Mounjaro? A comprehensive guide for men
What Mounjaro (tirzepatide) is, what it is licensed to treat in the UK, how its dual GIP and GLP-1 action works, its dosing, side effects and safety.
